Dr. Jamil Y. Abuzetun, MD

Dr. Abuzetun practices at The University of Kansas Health System Olathe Hospital in Olathe, Kansas, part of The University of Kansas Health System.

Dr. Abuzetun's NPI, 1124245659, was assigned on April 19, 2007. Dr. Abuzetun graduated from Jordan University of Science and Technology FOM in 2003. Dr. Abuzetun's Kansas license number on file is 04-40244.

Dr. Abuzetun's primary practice is The University of Kansas Health System Olathe Hospital, at 20333 West 151st Street, Olathe, KS 66061 in Johnson County. The practice phone is (913) 355-4200.

Dr. Abuzetun's primary practice is The University of Kansas Health System Olathe Hospital in Olathe, Kansas, part of The University of Kansas Health System. Dr. Abuzetun is also affiliated with The University of Kansas Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Abuzetun to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abuzetun practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Abuzetun's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Abuzetun is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Abuzetun's licenses on file in 3 states: Kansas, Nebraska and Iowa.

Dmand AI lists angioplasty, cardiac catheterization and pacemaker or defibrillator implantation among the conditions Dr. Abuzetun treats.

CMS data shows 2,483 Medicare services from Dr. Abuzetun across 29 procedure codes in 2024, for 1,030 Medicare patients. Medicare paid $144,699 for them.

CMS counts 1,030 Medicare patients who saw Dr. Abuzetun in 2024. The largest group is 65 to 74, with 452 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abuzetun's median patient age at 75, with 48% women.

In 2024, Dr. Abuzetun wrote 4,119 Medicare Part D claims for 566 patients. 85% of them were for generic drugs. CMS names the drug for 3,946 of them, across 39 drugs with 11 or more claims each, at $530,023 in total drug cost. In 2023, CMS named 3,796 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Abuzetun for performance year 2024, reported through an alternative payment model (APM). Dr. Abuzetun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of coronary angioplasty and stenting by Dr. Abuzetun, more than 71% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Abuzetun in 2008. 2008 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols and Tomography, X-Ray Computed. Dr. Abuzetun has published most often in Cases J. Dr. Abuzetun's most frequent co-authors are Charles A. Enke, MD, Aryan N. Mooss, MD and Ruby Satpathy, MD.

CMS Open Payments shows 63 general payments to Dr. Abuzetun from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Medtronic, Inc. paid the most, $499.

Dr. Abuzetun graduated from Jordan University of Science and Technology FOM in 2003. Dr. Abuzetun is a member of ACC.

Dr. Abuzetun is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.